Last Posted: Feb 13, 2020
- Molecular Therapies for Inherited Retinal Diseases-Current Standing, Opportunities and Challenges.
Vázquez-Domínguez Irene et al. Genes 2019 10(9) - Super-precise CRISPR tool enhanced by enzyme engineering: Improvements to a method known as base editing could pave the way for safer gene therapies.
H Ledford, Nature, February 11, 2020 - CRISPR takes on cancer
J Couzin-Frankel, Science, February 7, 2020 - Step aside CRISPR, RNA editing is taking off: Making changes to the molecular messengers that create proteins might offer flexible therapies for cancer, pain or high cholesterol, in addition to genetic disorders.
S Reardon, Nature, February 4, 2020 - Prime Time for Genome Editing?
Urnov Fyodor D et al. The New England journal of medicine 2020 01 (5) 481-484 - Genome Editing for Mucopolysaccharidoses.
Poletto Edina et al. International journal of molecular sciences 2020 Jan 21(2) - Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.
Li Hongyi et al. Signal transduction and targeted therapy 2020 1 - Beyond Mendelian Genetics: Anticipatory Biomedical Ethics and Policy Implications for the Use of CRISPR Together with Gene Drive in Humans.
Nestor Michael W et al. Journal of bioethical inquiry 2020 Jan - Navigating 2020 and beyond
Nature Genetics editorial, January 7, 2020 - Quest to use CRISPR against disease gains ground
H Ledford, Nature, January 6, 2020
.jpeg)
No hay comentarios:
Publicar un comentario